Search Results for keywords:"active pharmaceutical ingredients"

Search Results: keywords:"active pharmaceutical ingredients"

H. R. 6802 — To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
💰
December 14, 2023
Status:Introduced in House
Congress:118
Words:2,324
The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act, also known as the "RAPID Reserve Act" (H. R. 6802), aims to strengthen the supply chain of critical drugs and their active ingredients in the United States. It authorizes the Secretary of Health and Human...
Simple Explanation
The RAPID Reserve Act is like a plan to store extra medicine in case we run out during emergencies. It wants to make sure important medicines are made at home in the USA and saved up so people can always get them when needed.
H. R. 7709 — To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production.
March 15, 2024
Status:Introduced in House
Congress:118
Words:4,410
The bill, known as the "PREPARE ACT of 2024," aims to create a strategic reserve of active pharmaceutical ingredients (APIs) and key materials in the United States. It seeks to secure the domestic supply and production pipeline for essential generic medicines. The plan includes maintaining a...
Simple Explanation
The bill is like a big plan to make sure the United States has enough special ingredients to make important medicines right at home, so they don’t have to get them from faraway places. It’s about keeping a special list of these medicines and making sure there are safe spots to store and make them nearby.
H. R. 6895 — To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
December 22, 2023
Status:Introduced in House
Congress:118
Words:216
H. R. 6895 seeks to amend the National Defense Authorization Act for Fiscal Year 2023 to broaden federal support. This bill aims to include the manufacturing of active pharmaceutical ingredients and the key materials needed for these ingredients within the scope of...
Simple Explanation
This bill wants to help make medicines safer and faster by supporting the factories that create the important ingredients used in medicine, especially when health and defense are concerned.
H. R. 6897 — To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.
December 22, 2023
Status:Introduced in House
Congress:118
Words:485
H.R. 6897 is a bill that requires the Secretary of Defense to start a pilot program by January 1, 2025, to test new technologies in synthetic biology for making active pharmaceutical ingredients and key starting materials in the United States. This program aims to reduce the Department of...
Simple Explanation
H.R. 6897 is a plan for the U.S. military to try making important medicine ingredients in America instead of getting them from other countries, to keep everyone safe. They'll test new ways to do this starting in 2025 and see how well it works over three years.

Showing 1 to 4 of 4 results